Low-Dose Estramustine Phosphate Monotherapy in Castration-Resistant Prostate Cancer Patients
We retrospectively evaluated the efficacy and toxicity of low-dose estramustine phosphate (EMP) monotherapy in patients with castration-resistant prostate cancer (CRPC). We administered EMP at 140 or 280 mg/day to 89 patients between January 2003 and December 2012. None of the patients were receivin...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 63(2017), 2 vom: 28. Feb., Seite 57-62
|
|---|
| 1. Verfasser: |
Fukui, Tomohiro
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Nakamura, Kenji,
Sakatani, Toru,
Atsuta, Takeshi,
Kato, Takuma,
Fukumoto, Tetsuya,
Ito, Masaaki,
Inoue, Koji,
Terai, Akito |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | Japanese |
|---|
| Veröffentlicht: |
2017
|
|---|
| Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica
|
|---|
| Schlagworte: | Journal Article
Antineoplastic Agents, Hormonal
Estramustine
35LT29625A
Prostate-Specific Antigen
EC 3.4.21.77 |
|---|